E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup

Citation
Ra. Byrne et al., E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup, J UROL, 165(5), 2001, pp. 1473-1479
Citations number
20
Categorie Soggetti
Urology & Nephrology","da verificare
Journal title
JOURNAL OF UROLOGY
ISSN journal
00225347 → ACNP
Volume
165
Issue
5
Year of publication
2001
Pages
1473 - 1479
Database
ISI
SICI code
0022-5347(200105)165:5<1473:EIOBTC>2.0.ZU;2-W
Abstract
Purpose: We analyze the expression of E-cadherin in bladder transitional ce ll carcinoma, areas of carcinoma in situ and lymph node metastases, and det ermine the value of E-cadherin immunoreactivity for predicting disease prog ression and survival of patients with bladder transitional cell carcinoma. Materials and Methods: The study group consisted of 77 patients who underwe nt radical cystectomy. Formalin fixed paraffin sections were processed with a hot, citric acid antigen retrieval method, followed by immunostaining wi th anti-E-cadherin monoclonal antibody and a standard avidin biotin complex technique. E-cadherin expression was also evaluated in carcinoma in situ s ections (18) and in regional lymph node metastases (17). Results: Loss of normal membrane E-cadherin immunoreactivity was found in 5 9 (77%) patients. Abnormal expression of E-cadherin was associated with mus cle invasive disease (p = 0.010) and lymph node metastasis (p = 0.044). Of the 18 carcinoma in situ specimens 15 (83%) and of the 17 metastatic lymph nodes 13 (76%) had abnormal E-cadherin expression. Concordance rates of E-c adherin status in carcinoma in situ areas and metastatic lymph nodes with t he primary tumors were 85% and 88%, respectively. At a median followup of 1 28 months, abnormal E-cadherin expression was significantly associated with disease progression (p = 0.0219) and bladder cancer specific survival (p = 0.037). E-cadherin expression and pathological stage but not grade were in dependent predictors of disease progression (p = 0.042, 0.047 and 0.158, re spectively). Conclusions: In bladder cancer alter ed E-cadherin expression is associated with the degree of invasiveness, lymph node metastasis and increased risk of death from bladder cancer. Furthermore, E-cadherin status is an independ ent predictor of disease progression in patients treated with cystectomy fo r transitional cell carcinoma of the bladder.